Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Publisher Name :
Date: 01-Jan-2017
No. of pages: 100
Price : Single User: US $ 2000  US $ 1700 Corporate User: US $ 6000  US $ 4200
This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Report, "Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Interstitial Cystitis (Painful Bladder Syndrome) Report is to understand the market and pipeline status of the drugs around the Interstitial Cystitis (Painful Bladder Syndrome) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Interstitial Cystitis (Painful Bladder Syndrome). While the leading brands, companies and chemicals are considered thoroughly, DelveInsight's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 48-72 Hours to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • A snapshot of the global Market and Phase III therapeutics scenario for Interstitial Cystitis (Painful Bladder Syndrome).

  • A review of the marketed products under prescription for Interstitial Cystitis (Painful Bladder Syndrome), regulatory information and marketing status.

  • Coverage of global patent coverage and detailed commentaries on the US patent challenges.

  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

  • Product profiles for marketed products for Interstitial Cystitis (Painful Bladder Syndrome) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

  • Coverage of API Manufacturers for Interstitial Cystitis (Painful Bladder Syndrome) drugs in the United States, Europe and Asian Regions with location details.

  • Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Interstitial Cystitis (Painful Bladder Syndrome) drugs.

  • Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Interstitial Cystitis (Painful Bladder Syndrome) drugs.

  • Coverage of Interstitial Cystitis (Painful Bladder Syndrome) Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.

  • Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.

  • Key discontinued Marketed products.

  • Global Sales Figure to 2018.

Reasons to buy

  • Evaluate the marketing status and exclusivity details of Interstitial Cystitis (Painful Bladder Syndrome) key products to exploit opportunities for generic drug development opportunities.

  • Identify and understand important and diverse types of therapeutics under Phase III development for Interstitial Cystitis (Painful Bladder Syndrome).

  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Interstitial Cystitis (Painful Bladder Syndrome).

  • API intelligence over marketed drugs forInterstitial Cystitis (Painful Bladder Syndrome)and gaining primary intelligence over active ingredients manufacturers across the globe.

  • API intelligence over leading Phase III Pipeline drugs.

  • Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

  • Understanding the scope of the Phase III Drugs with nil regulatory filings.

  • Understanding the chemical route of synthesis of approved drugs for Interstitial Cystitis (Painful Bladder Syndrome).

  • Uncovering opportunities in the rapidly growing US market.

This report is available at 15% Discount for Single User License and 30% Discount for Corporate Users License till 30 June 2017. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.

Interstitial Cystitis (Painful Bladder Syndrome)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

Table of Contents

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Interstitial Cystitis (Painful Bladder Syndrome)
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Interstitial Cystitis (Painful Bladder Syndrome)
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Interstitial Cystitis (Painful Bladder Syndrome)
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables

Interstitial Cystitis (Painful Bladder Syndrome) Therapeutic Market, US, Marketed Drugs by Application Type, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutic Market, US, (Year), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Marketed Drugs, API Manufacturers by US DMF Status, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Marketed Drugs, US DMF Status Drug Specific (Number), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Drugs, API Manufacturers, Europe by Country, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Drugs, API Manufacturers, India by State, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Drugs, API Manufacturers, China by Province, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Drugs, API Manufacturers by Geography 2017
Interstitial Cystitis (Painful Bladder Syndrome) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutic Market, Global Sales-2018 (in million USD)
API Manufacturers for Drug, 2017
Phase III Drugs for Interstitial Cystitis (Painful Bladder Syndrome), 2017
Discontinued Drugs for Interstitial Cystitis (Painful Bladder Syndrome), 2017

List of Figures

Interstitial Cystitis (Painful Bladder Syndrome) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutic Market, US, (Year), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Marketed Drugs, API Manufacturers by US DMF Status (%), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Marketed Drugs, US DMF Status Drug Specific (Number), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Drugs, API Manufacturers, Europe by Country, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Drugs, API Manufacturers, India by State, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Drugs, API Manufacturers, China by Province, 2017
Interstitial Cystitis (Painful Bladder Syndrome) Drugs, API Manufacturers by Geography 2017
Interstitial Cystitis (Painful Bladder Syndrome) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2017
Interstitial Cystitis (Painful Bladder Syndrome) Therapeutic Market, Global Sales 2018 (in million USD)
Drug, Patent/Exclusivity Expiry (Year), 2017
  • Renewable Energy Sources Needs To Boost Global Microgrids Market
    The global market for microgrid was worth US$13.3 billion in 2015, and is anticipated to touch an estimate of US$35.2 billion by 2020. Dealers in the market for microgrids are incessantly improving the network hosting capability for renewable energy resources to excerpt an extreme amount from it, in addition to commercialization of classically costly renewable […]
  • Manufacturing Trends In The Coming Days
    The manufacturing industry may be encountering some breezes, but it is irrefutably in the middle of a technological revival that is altering the appearance, structures, and practices of the modern factory. Notwithstanding the jeopardies and in spite of recent history industrial manufacturing enterprises cannot afford to disregard these developments. Few of the trends to look […]
  • Top 10 Emerging Technologies
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or environmental jeopardies […]
  • Global Biosimilars Market To Be Led By Novartis by 2020
    Biologics, which are typically inoculated or injected, are formed in living entities, making them more challenging and costly to manufacture than the usual pills contrived from chemicals. Observing that mock-ups are mostly identical to the prototypes has also modelled specific scientific and regulatory tasks. But the US FDA and European supervisors lately have acknowledged new […]
  • Global Thyroid Gland Disorder Treatment Market To Grow Steadily
    The global thyroid gland disorder treatment market was worth US$1.8 billion in 2014 and is projected to reach a market value of US$2.4 billion in 2023 intensifying at a CAGR of 3.1% from 2015 to 2023.  The thyroid gland produces thyroid hormones that control some of the most essential functions in the human body such as stimulating […]
  • EMEA (Europe, Middle East and Africa) Genitourinary Drugs Market Report 2017
    Published: 20-Jun-2017        Price: US 4000 Onwards        Pages: 114
    In this report, the EMEA Genitourinary Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Genitourinary Drugs for these regions, from 2012 to 2022 (forecast) - Europe: Germany, France, UK, Russia, Italy and Benelux;......
  • Overactive Bladder - Pipeline Review, H1 2017
    Published: 09-May-2017        Price: US 2000 Onwards        Pages: 114
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder - Pipeline Review, H1 2017, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.Overactive bladder is a problem with bladder-storage function that causes a sudden urge to urinate. The urge may be difficult to stop, and overactive bladder may lead to the involuntary loss of urine (incontinence). Symptoms include feel a sudden urge to urin......
  • Interstitial Cystitis - Pipeline Review, H1 2017
    Published: 28-Apr-2017        Price: US 2000 Onwards        Pages: 82
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Interstitial Cystitis - Pipeline Review, H1 2017, provides an overview of the Interstitial Cystitis (Genito Urinary System And Sex Hormones) pipeline landscape. Interstitial cystitis also called painful bladder syndrome is a chronic condition in which person experience bladder pressure, bladder pain and sometimes pelvic pain, ranging from mild discomfort to severe pain. Symptoms include decreased bladd......
  • Urinary Incontinence - Market Insights, Epidemiology and Market Forecast -2023-7MM
    Published: 01-Apr-2017        Price: US 4950 Onwards        Pages: 77
    DelveInsight's "Urinary Incontinence - Market Insights, Epidemiology and Market Forecast-2023-7MM" Reports provides an overview of the disease and global market size of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023. Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage......
  • Interstitial Cystitis - Epidemiology Insights -2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 51
    DelveInsight's "Interstitial Cystitis - Epidemiology Insights -2023" Reports provides an overview of the disease. The Report includes global forecast of epidemiology of Interstitial Cystitis till 2023. Interstitial cystitis (IC) also known as painful bladder syndrome is a chronic disease that results in recurring discomfort or pain in the bladder and the surrounding pelvic region. This is considered as multiple bladder condition as it can lead to many other problems. Current studies estimate tha......
  • Urinary Incontinence - Epidemiology Forecast To 2023
    Published: 01-Apr-2017        Price: US 2750 Onwards        Pages: 51
    DelveInsight's Urinary Incontinence - Epidemiology Forecast To 2023" Reports provides an overview of the disease and epidemiology trends of the Urinary Incontinence for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the prevalent cases of Urinary Incontinence from 2013-2023. Urinary Incontinence is a multifactorial syndrome which occurs due to the failure of the storage function of the lower urinary......
  • Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023
    Published: 01-Apr-2017        Price: US 4950 Onwards        Pages: 73
    DelveInsight's "Interstitial Cystitis - Market Insights, Epidemiology and Market Forecast-2023" Reports provides an overview of the disease and global market trends of the Interstitial Cystitis for the seven major markets i.e. United States, Europe (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue, treatment practice and Interstitial Cystitis forecasted market share from 2017 to 2023 segmented by seven major markets. In addition, the report also inc......
  • Pyelonephritis - Pipeline Review, H1 2017
    Published: 31-Mar-2017        Price: US 2000 Onwards        Pages: 58
    Pyelonephritis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pyelonephritis - Pipeline Review, H1 2017, provides an overview of the Pyelonephritis (Infectious Disease) pipeline landscape. Pyelonephritis is a specific type of urinary tract infection (UTI) that generally begins in urethra or bladder and travels up into kidneys. Signs and symptoms include fever, abdominal pain, freque......
  • Nocturia - Pipeline Review, H1 2017
    Published: 28-Feb-2017        Price: US 2000 Onwards        Pages: 33
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nocturia - Pipeline Review, H1 2017, provides an overview of the Nocturia (Genito Urinary System And Sex Hormones) pipeline landscape.Nocturia is defined as need to urinate at least twice during the night. This condition becomes more common as people age and occurs in both men and women, sometimes for different reasons. Causes of nocturia include congestive heart failure, edema of lower extremities, sleeping d......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs